In a report released today, Jailendra Singh from Truist Financial maintained a Buy rating on Icon (ICLR – Research Report). The company’s ...
ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2025.